BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 197028)

  • 1. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR; Baldwin RW
    Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-dependent cytotoxicity against hepatoma cells mediated by IgM antibodies in serum from tumor-bearing rats.
    Lando P; Blomberg F; Raftell M; Berzins K; Perlmann P
    Scand J Immunol; 1977; 6(11):1081-92. PubMed ID: 202015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.
    Höffken K; Price MR; Moore VE; Baldwin RW
    Int J Cancer; 1978 Nov; 22(5):576-82. PubMed ID: 214404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of aminoazo dye induced rat hepatoma membrane fractions retaining tumour specific antigen.
    Price MR; Baldwin RW
    Br J Cancer; 1974 Nov; 30(5):382-93. PubMed ID: 4143271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of tumour-specific antigen from the serum of rats bearing transplanted aminoazo dye-induced hepatomas.
    Bowen JG; Baldwin RW
    Transplantation; 1976 Mar; 21(3):213-9. PubMed ID: 59982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties of rat hepatoma subcellular fractions.
    Price MR; Baldwin RW
    Br J Cancer; 1974 Nov; 30(5):394-400. PubMed ID: 4377707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microassay for the detection of tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR
    Transplantation; 1978 Apr; 25(4):224-5. PubMed ID: 205018
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.
    Bowen JG; Robins RA; Baldwin RW
    Int J Cancer; 1975 Apr; 15(4):640-50. PubMed ID: 166943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA
    Br J Cancer; 1975 Jul; 32(1):21-7. PubMed ID: 169868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum.
    Baldwin RW; Bowen JG; Price MR
    Br J Cancer; 1973 Jul; 28(1):16-24. PubMed ID: 4353387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1976 Jan; 17(1):129-37. PubMed ID: 175021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatoma associated embryonic antigen in tumour-bearer serum.
    Rees RC; Price MR; Shan LP; Baldwin RW
    Transplantation; 1975 May; 19(5):424-9. PubMed ID: 168675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity to chemically-induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Int J Cancer; 1975 Oct; 16(4):593-606. PubMed ID: 170224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas.
    Baldwin RW; Embleton MJ
    Int J Cancer; 1971 Jan; 7(1):17-25. PubMed ID: 4322936
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum factor levels during the growth of rat hepatoma nodules in the lungs.
    Bowen JG; Baldwin RW
    Int J Cancer; 1976 Feb; 17(2):254-60. PubMed ID: 175030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of rat hepatoma membrane fractions.
    Baldwin RW; Embleton MJ; Moore M
    Br J Cancer; 1973 Nov; 28(5):389-99. PubMed ID: 4357132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response of the draining and distal lymph nodes during the progressive grwoth of a chemically-induced transplantable rat hepatoma.
    Jones JA; Robinson G; Rees RC; Baldwin RW
    Int J Cancer; 1978 Feb; 21(2):171-8. PubMed ID: 203547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of syngeneic complement for revealing antibody-induced cytotoxicity against a rat hepatoma.
    Price MR; Höffken K; Baldwin RW
    Transplantation; 1979 Aug; 28(2):140-3. PubMed ID: 483360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic antigen expression in chemically induced rat hepatomas and sarcomas.
    Baldwin RW; Glaves D; Vose BM
    Int J Cancer; 1972 Sep; 10(2):233-43. PubMed ID: 4350186
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.
    Baldwin RW; Price MR; Robins RA
    Int J Cancer; 1973 May; 11(3):527-35. PubMed ID: 4364717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.